Diagnosis and Treatment of Bladder Cancer: How Can We Improve?

Screening Adults for Bladder Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force

(2013) Roger Chou   ANNALS OF INTERNAL MEDICINE

Screening for Bladder Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard

(2011) Björn L. Isfoss   BJU INTERNATIONAL

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update

(2011) Marko Babjuk et al.   EUROPEAN UROLOGY

Smoking Knowledge Assessment and Cessation Trends in Patients With Bladder Cancer Presenting to a Tertiary Referral Center

(2011) Thomas J. Guzzo et al.   UROLOGY

Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate

(2011) Evelyne C. C. Cauberg et al.   WORLD JOURNAL OF UROLOGY

Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer

(2010) Aref M. Maarouf et al.   BJU INTERNATIONAL

Radical cystectomy for BCG failure: has the timing improved in recent years?

(2010) Mark S. Soloway et al.   BJU INTERNATIONAL

Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy

(2010) Harry W. Herr et al.   BJU INTERNATIONAL

Delays in diagnosis and bladder cancer mortality

(2010) Brent K. Hollenbeck et al.   CANCER

Intravesical therapy for superficial bladder cancer: A systematic review of randomised trials and meta-analyses

(2010) Mike D. Shelley et al.   CANCER TREATMENT REVIEWS

Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer

(2010) Arnulf Stenzl et al.   JOURNAL OF UROLOGY

Occupation and bladder cancer in a population-based case-control study in Northern New England

(2010) J. S. Colt et al.   OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Environmental factors and genetic susceptibility promote urinary bladder cancer

(2010) Dimitrios Volanis et al.   TOXICOLOGY LETTERS

Environmental factors promoting bladder cancer

(2009) Yoshihiko Hirao et al.   CURRENT OPINION IN UROLOGY

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

(2009) Per-Uno Malmström et al.   EUROPEAN UROLOGY

Updated results of bladder-sparing trimodality approach for invasive bladder cancer

(2009) Almudena Zapatero et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer

(2009) Michael P. Porter et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

(2008) Fabio Calabrò et al.   EUROPEAN UROLOGY

The Causal Role of Cigarette Smoking in Bladder Cancer Initiation and Progression, and the Role of Urologists in Smoking Cessation

(2008) Seth A. Strope et al.   JOURNAL OF UROLOGY

Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey

(2008) Alan M. Nieder et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS